They Don’t Just Take a Random Egg: Egg Selection in the United States

  • Lauren Jade Martin


This chapter examines how the United States fertility industry relies upon the ideology of eugenic selection and the genetic capacity of gametes to market egg donation services globally. Egg donors are selected based on physical, racial, and personality traits that clinics and agencies perceive will appeal to intended parents. By appealing to intended parents to come to the United States as a means to “select” traits in their future offspring by way of egg donation, American fertility industry practices may serve to undermine officially sanctioned norms and values regarding eugenics and selection in those intended parents’ own countries.


Egg donation Gametes Fertility industry Eugenics The United States 


  1. A Perfect Match. 2008a. Egg Donation Program. Accessed 30 May 2015.
  2. ———. 2008b. For Donors. Accessed 17 April 2011.
  3. Almeling, R. 2011. Sex Cells: The Medical Market for Eggs and Sperm. Berkeley: University of California Press.Google Scholar
  4. Anderson, B. 1991. Imagined Communities. Revised ed. London: Verso.Google Scholar
  5. Caucasian, Educated Donor Needed! **$50,000 a Cycle**. n.d. Accessed 30 May 2015.
  6. Cooper, M., and C. Waldby. 2014. Clinical Labor: Tissue Donors and Research Subjects in the Global Bioeconomy. Durham and London: Duke University Press.CrossRefGoogle Scholar
  7. Davis, A.Y. 1993. Outcast Mothers and Surrogates: Racism and Reproductive Rights in the Nineties. In American Feminist Thought at Century’s End: A Reader, ed. L.S. Kauffman, 355–366. Cambridge: Wiley-Blackwell.Google Scholar
  8. Donor Concierge. 2013. International Services. Accessed 25 August 2013.
  9. Duster, T. 2003. Backdoor to Eugenics. New York: Routledge.CrossRefGoogle Scholar
  10. Egg Donation Inc. 2015. Donor Profile JODI (#57450). Accessed 30 May 2015.
  11. Ethics Committee of the American Society for Reproductive Medicine. 2007. Financial Compensation of Oocyte Donors. Fertility and Sterility 88 (2): 305–309.CrossRefGoogle Scholar
  12. European Society of Human Reproduction and Embryology. 2006. Spanish Legislation: Donor Anonymity. Accessed 6 September 2012.
  13. Fertility Center and Applied Genetics of Florida. 2013. International Patients. Accessed 22 August 2013.
  14. Fujimura, J.H., R. Rajagopalan, and T. Duster. 2008. Introduction Race, Genetics, and Disease: Questions of Evidence, Matters of Consequence. Social Studies of Science 38 (5): 643–656.CrossRefGoogle Scholar
  15. Haller, M.H. 1963. Eugenics: Hereditarian Attitudes in American Thought. New Brunswick, NJ: Rutgers University Press.Google Scholar
  16. Hudson, N., L. Culley, E. Blyth, W. Norton, F. Rapport, and A. Pacey. 2011. Cross-Border Reproductive Care: A Review of the Literature. Reproductive BioMedicine Online 22 (7): 673–685.CrossRefGoogle Scholar
  17. Human Fertilisation and Embryology Authority. 2011a. Donor Compensation, Reimbursement and Benefits in Kind. Accessed 17 April 2011.
  18. ———. 2011b. The Changing Landscape of Donation. Accessed 23 April 2011.
  19. Inhorn, M.C., and Z. Gürtin. 2011. Cross-Border Reproductive Care: A Future Research Agenda. Reproductive BioMedicine Online 23 (5): 665–676.CrossRefGoogle Scholar
  20. Jones, H.W., I. Cooke, R. Kempers, P. Brinsden, and D. Saunders. 2010. IFFS Surveillance 2010. Accessed 24 April 2011.
  21. Kevles, D.J. 1995. In the Name of Eugenics: Genetics and the Uses of Human Heredity. Cambridge, MA: Harvard University Press.Google Scholar
  22. Martin, L.J. 2014. The World’s Not Ready for This: Globalizing Selective Technologies. Science, Technology and Human Values 39 (3): 432–455.CrossRefGoogle Scholar
  23. ———. 2015. Reproductive Tourism in the United States: Creating Family in the Mother Country. New York: Routledge.Google Scholar
  24. Moore, L.J. 2007. Sperm Counts: Overcome by Man’s Most Precious Fluid. New York: New York University Press.Google Scholar
  25. Nygren, K., D. Adamson, F. Zegers-Hochschild, and J. de Mouzon. 2010. Cross-Border Fertility Care—International Committee Monitoring Assisted Reproductive Technologies Global Survey: 2006 Data and Estimates. Fertility and Sterility 94 (1): e4–e10.CrossRefGoogle Scholar
  26. PAMF Fertility Physicians of Northern California. 2015. Egg Donors of All Ethnicities Needed! ($7000+ & $200 Upon Approval). Accessed 30 May 2015.
  27. Roberts, D. 2011. Fatal Invention: How Science, Politics, and Big Business Re-create Race in the Twenty-First Century. New York: The New Press.Google Scholar
  28. Rothman, B.K. 2001. The Book of Life: A Personal and Ethical Guide to Race, Normality, and the Implications of the Human Genome Project. Boston, MA: Beacon Press.Google Scholar
  29. Spar, D. 2006. The Baby Business: How Money, Science, and Politics Drive the Commerce of Conception. Boston, MA: Harvard Business School Press.Google Scholar
  30. Twine, F.W. 2011. Outsourcing the Womb: Race, Class and Gestational Surrogacy in a Global Market. New York and London: Routledge.Google Scholar
  31. U.S. Department of Health and Human Services. 2007. Guidance for Industry: Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products. Rockville, MD.
  32. West Coast Egg Donation. 2015. Egg Donor Database. Accessed 30 May 2015.

Copyright information

© The Author(s) 2018

Authors and Affiliations

  • Lauren Jade Martin
    • 1
  1. 1.Penn State University, BerksReadingUSA

Personalised recommendations